Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2000 | 1 |
2016 | 1 |
2017 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A.
Blood. 2017 Mar 9;129(10):1245-1250. doi: 10.1182/blood-2016-06-720086. Epub 2016 Dec 29.
Blood. 2017.
PMID: 28034891
Free article.
Clinical Trial.
Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis.
Rosendaal FR, Palla R, Garagiola I, Mannucci PM, Peyvandi F; SIPPET Study Group.
Rosendaal FR, et al.
Blood. 2017 Oct 12;130(15):1757-1759. doi: 10.1182/blood-2017-06-791756. Epub 2017 Aug 2.
Blood. 2017.
PMID: 28768627
Free article.
Clinical Trial.
Item in Clipboard
A t(1;22)(p13;q13) in four children with acute megakaryoblastic leukemia (M7), two with Down syndrome.
Trejo RM, Aguilera RP, Nieto S, Kofman S.
Trejo RM, et al. Among authors: aguilera rp.
Cancer Genet Cytogenet. 2000 Jul 15;120(2):160-2. doi: 10.1016/s0165-4608(99)00251-4.
Cancer Genet Cytogenet. 2000.
PMID: 10942809
Item in Clipboard
Cite
Cite